Ablacon, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://ablacon.com
Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
FLOW EVAL-AF: FLOW Mapping Electrogram VALidation in Patients With Persistent Atrial Fibrillation
- Conditions
- Longstanding Persistent Atrial FibrillationPersistent Atrial FibrillationAtrial Fibrillation, PersistentArrhythmias, Cardiac
- First Posted Date
- 2024-02-15
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Ablacon, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT06260670
- Locations
- 🇩🇪
Herz-und Diabeteszentrum NRW (Clinic of Ruhr University of Bochum), Bad Oeynhausen, North Rhine-Westphalia, Germany
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
- Conditions
- ArrhythmiaAtrial Fibrillation, PersistentAtrial Fibrillation ParoxysmalArrhythmias, CardiacAtrial FibrillationAtrial TachycardiaAtrial FlutterAtrial Fibrillation, Paroxysmal or PersistentAtrial Arrhythmia
- First Posted Date
- 2023-06-01
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Cortex
- Target Recruit Count
- 400
- Registration Number
- NCT05883631
- Locations
- 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸Grandview Medical Center, Birmingham, Alabama, United States
🇺🇸Banner Health, Phoenix, Arizona, United States
AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation
- Conditions
- Atrial Fibrillation, PersistentAtrial FibrillationArrhythmias, CardiacHeart Diseases
- First Posted Date
- 2022-08-01
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Ablacon, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT05481359
- Locations
- 🇺🇸
Piedmont Atlanta Hospital, Atlanta, Georgia, United States
🇳🇱Erasmus MC, Rotterdam, Zuid Holland, Netherlands
🇵🇱Medicover Hospital, Warsaw, Poland
FLOW-AF: A Study to Evaluate Electrographic Flow™ (EGF) Mapping Technology
- Conditions
- Atrial Fibrillation, Persistent
- First Posted Date
- 2020-07-16
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Cortex
- Target Recruit Count
- 85
- Registration Number
- NCT04473963
- Locations
- 🇩🇪
Practice Clinic Heart And Vessels, Dresden, Saxony Land, Germany
🇩🇪University Heart and Vascular Center Hamburg, Hamburg, Germany
🇳🇱Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands